Small Cell Lung Cancer: ZL-1310 Study

We are testing different doses of ZL-1310 in patients with small cell lung cancer. The goal is to find a suitable dose and see how well the body tolerates and processes the medication.

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Vall D Hebron Institute Of Oncology
Oncology Department
Alboraya, Spain
Hospital Hm Nou Delfos
Oncology Department
Barcelona, Spain
Hospital Universitario Hm Sanchinarro
Oncology Department
Chamartín, Spain

Sponsor: Zai Lab (Shanghai) Co. Ltd.
Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.